Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Bristol-Myers Squibb Company (BMY)

Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 82,077,280
  • Shares Outstanding, K 2,027,100
  • Annual Sales, $ 45,006 M
  • Annual Income, $ 8,025 M
  • 60-Month Beta 0.45
  • Price/Sales 1.86
  • Price/Cash Flow 3.31
  • Price/Book 5.05
Trade BMY with:

Options Overview Details

View History
  • Implied Volatility 25.50% ( +1.74%)
  • Historical Volatility 29.22%
  • IV Percentile 79%
  • IV Rank 63.73%
  • IV High 30.66% on 01/29/24
  • IV Low 16.43% on 06/16/23
  • Put/Call Vol Ratio 0.65
  • Today's Volume 50,481
  • Volume Avg (30-Day) 41,875
  • Put/Call OI Ratio 0.78
  • Today's Open Interest 691,398
  • Open Int (30-Day) 628,712

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 1.67
  • Number of Estimates 11
  • High Estimate 1.79
  • Low Estimate 1.55
  • Prior Year 1.75
  • Growth Rate Est. (year over year) -4.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
40.38 +0.27%
on 05/28/24
45.72 -11.43%
on 05/14/24
-4.36 (-9.72%)
since 04/26/24
3-Month
40.38 +0.27%
on 05/28/24
55.03 -26.43%
on 03/13/24
-10.43 (-20.48%)
since 02/28/24
52-Week
40.38 +0.27%
on 05/28/24
66.46 -39.08%
on 06/05/23
-23.33 (-36.56%)
since 05/26/23

Most Recent Stories

More News
Biotech Sector Working to Combat Rising Cases of Colorectal Cancer in Young Adults

/CNW/ -- USA News Group – Rates of cancer of the colorectal and anal regions have been on the rise for years in young adults, according to surgeons at Yale...

ONCY : 1.1000 (+0.92%)
TCRX : 8.74 (+3.92%)
BMY : 40.49 (-1.82%)
PDSB : 3.11 (+0.97%)
CCCC : 5.36 (-2.19%)
ONC.TO : 1.49 (-2.61%)
This Unpopular Dividend Stock Is a Buy

This top pharma stock has fallen too far.

BMY : 40.49 (-1.82%)
1 Stock I Wouldn't Touch With a 10-Foot Pole

This stock isn't as safe as it seems, and now isn't the time to dabble.

BMY : 40.49 (-1.82%)
Do Wall Street Analysts Like Bristol-Myers Squibb Stock?

Bristol-Myers Squibb stock has significantly trailed the broader market this year, and Wall Street remains wary on the stock’s prospects.

BMY : 40.49 (-1.82%)
$SPX : 5,306.04 (+0.02%)
IHE : 65.03 (-0.63%)
Down but Not Out: 3 Stocks to Buy on a Post-Earnings Dip

Bad news can be good news for an enterprising investor with a longer time horizon than the market's immediate reaction.

MCD : 253.54 (-1.77%)
SBUX : 77.48 (-1.76%)
DDOG : 122.11 (-1.21%)
BMY : 40.49 (-1.82%)
Is Bristol Myers' Dividend in Danger?

Should investors brace for a dividend cut?

BMY : 40.49 (-1.82%)
2 Beaten-Down Stocks to Buy and Hold for 10 Years

They offer plenty of upside and solid dividend growth.

BMY : 40.49 (-1.82%)
PFE : 28.30 (-2.01%)
Could Investing $100,000 in Bristol Myers Squibb Stock Make You a Millionaire?

Keep your goals in check when considering an extreme contrarian trade with Bristol Myers Squibb stock.

BMY : 40.49 (-1.82%)
If You'd Invested $1,000 in Bristol Myers Squibb 5 Years Ago, Here's How Much You'd Have Today

The answer isn't great, but there's still reason to like Bristol Myers Squibb.

BMY : 40.49 (-1.82%)
3 Top ETFs to Buy for Passive Income in May

These ETFs provide investors with above-average income streams.

TXN : 199.60 (+0.21%)
PEP : 173.38 (-2.59%)
SPHY : 23.16 (-0.34%)
VZ : 39.36 (-0.96%)
BMY : 40.49 (-1.82%)
LMT : 458.48 (-1.90%)
SCHW : 70.79 (-2.05%)
JPM : 199.50 (-0.60%)
SCHD : 77.44 (-0.85%)
JEPQ : 54.55 (+0.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers...

See More

Key Turning Points

3rd Resistance Point 42.03
2nd Resistance Point 41.68
1st Resistance Point 41.08
Last Price 40.49
1st Support Level 40.14
2nd Support Level 39.79
3rd Support Level 39.19

See More

52-Week High 66.46
Fibonacci 61.8% 56.50
Fibonacci 50% 53.42
Fibonacci 38.2% 50.34
Last Price 40.49
52-Week Low 40.38

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar